VAXNEUVANCE

This brand name is authorized in Estonia, Finland, Ireland, Japan, Poland, Romania, Turkey, United States

Active ingredients

The drug VAXNEUVANCE contains a combination of these active pharmaceutical ingredients (APIs):

1 Pneumococcal polysaccharide, serotype 1 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

2 Pneumococcal polysaccharide, serotype 3 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

3 Pneumococcal polysaccharide, serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

4 Pneumococcal polysaccharide, serotype 5 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

5 Pneumococcal polysaccharide, serotype 6A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

6 Pneumococcal polysaccharide, serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

7 Pneumococcal polysaccharide, serotype 7F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

8 Pneumococcal polysaccharide, serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

9 Pneumococcal polysaccharide, serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

10 Pneumococcal polysaccharide, serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

11 Pneumococcal polysaccharide, serotype 19A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

12 Pneumococcal polysaccharide, serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

13 Pneumococcal polysaccharide, serotype 22F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

14 Pneumococcal polysaccharide, serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

15 Pneumococcal polysaccharide, serotype 33F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VAXNEUVANCE Suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AL02	Pneumococcus, purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1871164, 1871175
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 481047
Country: JP	医薬品医療機器総合機構	Identifier(s): 631140KG1020
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100448690
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68336001, W68336002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636951576, 8699636951583, 8699636951590
Country: US	FDA, National Drug Code	Identifier(s): 0006-4329